Zucomet VG 2mg/500mg/0.2mg Tablet
Marketer
Zuciya Lifesciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Zucomet VG 2mg/500mg/0.2mg Tablet
Diabetic patients using the anti-diabetic medication, Voglibose-Pioglitazone-Metformin 2mg/500mg/0.2mg tablets, should be aware this combination therapy manages type 2 diabetes in adults by regulating blood glucose. Administer this medication orally with food, consistently at the same time daily, as prescribed. Dosage adjustments depend on individual response and blood sugar monitoring. Discontinuation requires medical supervision; abrupt cessation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, necessitating adherence to dietary recommendations, regular exercise, and weight management strategies as directed by your physician. Hypoglycemia (low blood sugar) is a common adverse effect; symptoms include sweating, dizziness, headache, and tremors. Carrying a fast-acting glucose source is recommended, and alcohol should be avoided as it increases hypoglycemia risk. Other potential side effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and significant hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals should seek medical consultation. Regular blood glucose monitoring is essential, along with potential blood tests for hematological and hepatic function assessments.
Primary Ingredients of Zucomet VG 2mg/500mg/0.2mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Zucomet VG 2mg/500mg/0.2mg Tablet
Managing Type 2 Diabetes
Major Benefits of Zucomet VG 2mg/500mg/0.2mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Zucomet VG 2mg/500mg/0.2mg Tablet on an empty stomach.
Common Side effects of Zucomet VG 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Zucomet VG 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Zucomet VG 2mg/500mg/0.2mg Tablet on an empty stomach.
How Zucomet VG 2mg/500mg/0.2mg Tablet works:
Each Zucomet VG tablet (2mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zucomet VG 2mg/500mg/0.2mg Tablet with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Zucomet VG 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Zucomet VG 2mg/500mg/0.2mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Zucomet VG 2mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Zucomet VG 2mg/500mg/0.2mg Tablets is contraindicated in patients experiencing severe kidney impairment.
LiverCAUTION
Exercise caution when prescribing Zucomet VG 2mg/500mg/0.2mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate treatment with a reduced Zucomet VG 2mg/500mg/0.2mg tablet dose; the medication is contraindicated in those with severe liver disease.
What if you forget to take Zucomet VG 2mg/500mg/0.2mg Tablet :
Should you forget a Zucomet VG 2mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Zucomet VG 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently